Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. FLNC
2. CRM
3. GNRC
4. SPY
5. CRWV
6. META
7. APO
8. BCBP
9. LSCC
10. ZENA

Go back to Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.35 --0 (-0%)
Previous Close $9.35    52 Week High $9.23 
Open $9.35    52 Week Low $1.16 
Day High $9.35    P/E N/A 
Day Low $9.35    EPS $-0.30 
Volume 10,609